Study

EORTC-62063

A phase III randomized study evaluating surgery of residual disease in patients with metastatic gastro-intestinal stromal tumor responding to Imatinib mesylate.

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 20-May-2009
Date Step1 close: 11-Mar-2011

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 280 - All Groups: 350

Protocol summary

http://clinicaltrials.gov/study/NCT00956072

NCT number

NCT00956072

EudraCT

2007-002257-23